Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor
- PMID: 31304403
- PMCID: PMC6591226
- DOI: 10.1038/s41746-019-0130-0
Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor
Abstract
Hypertrophic cardiomyopathy (HCM) is a heritable disease of heart muscle that increases the risk for heart failure, stroke, and sudden death, even in asymptomatic patients. With only 10-20% of affected people currently diagnosed, there is an unmet need for an effective screening tool outside of the clinical setting. Photoplethysmography uses a noninvasive optical sensor incorporated in commercial smart watches to detect blood volume changes at the skin surface. In this study, we obtained photoplethysmography recordings and echocardiograms from 19 HCM patients with left ventricular outflow tract obstruction (oHCM) and a control cohort of 64 healthy volunteers. Automated analysis showed a significant difference in oHCM patients for 38/42 morphometric pulse wave features, including measures of systolic ejection time, rate of rise during systole, and respiratory variation. We developed a machine learning classifier that achieved a C-statistic for oHCM detection of 0.99 (95% CI: 0.99-1.0). With further development, this approach could provide a noninvasive and widely available screening tool for obstructive HCM.
Keywords: Diagnostic markers; Translational research.
Conflict of interest statement
Competing interestsM.J.S. is an employee and owns shares in MyoKardia, Inc., a biotechnology company developing small molecules that target the sarcomere for the treatment of cardiomyopathies. R.vanM. and O.D. are employees and own shares in Wavelet Health. C.W. owns shares in MyoKardia, Inc. Support for these studies was provided by MyoKardia. The remaining authors declare no competing interests.
Figures

Comment in
-
Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor.NPJ Digit Med. 2019 Dec 10;2:120. doi: 10.1038/s41746-019-0186-x. eCollection 2019. NPJ Digit Med. 2019. PMID: 31840091 Free PMC article. No abstract available.
Similar articles
-
Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.J Am Coll Cardiol. 2014 Nov 11;64(19):1984-95. doi: 10.1016/j.jacc.2014.04.090. Epub 2014 Nov 3. J Am Coll Cardiol. 2014. PMID: 25440093
-
Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.J Am Coll Cardiol. 2013 Aug 27;62(9):842-50. doi: 10.1016/j.jacc.2013.06.007. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810875
-
Does Disopyramide Still Have a Place in the Management of Obstructive Hypertrophic Cardiomyopathy?CJC Open. 2024 Mar 15;6(6):811-817. doi: 10.1016/j.cjco.2024.03.006. eCollection 2024 Jun. CJC Open. 2024. PMID: 39022164 Free PMC article. Review.
-
Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy--the lobster claw abnormality.J Am Soc Echocardiogr. 1997 Sep;10(7):707-12. doi: 10.1016/s0894-7317(97)70112-3. J Am Soc Echocardiogr. 1997. PMID: 9339420
-
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.J Am Coll Cardiol. 2009 Jul 14;54(3):191-200. doi: 10.1016/j.jacc.2008.11.069. J Am Coll Cardiol. 2009. PMID: 19589431 Review.
Cited by
-
Green chemistry and coronavirus.Sustain Chem Pharm. 2021 Jun;21:100415. doi: 10.1016/j.scp.2021.100415. Epub 2021 Mar 3. Sustain Chem Pharm. 2021. PMID: 33686371 Free PMC article. Review.
-
A Framework for Biosensors Assisted by Multiphoton Effects and Machine Learning.Biosensors (Basel). 2022 Sep 1;12(9):710. doi: 10.3390/bios12090710. Biosensors (Basel). 2022. PMID: 36140093 Free PMC article. Review.
-
Usability of a Wrist-Worn Smartwatch in a Direct-to-Participant Randomized Pragmatic Clinical Trial.Digit Biomark. 2019 Dec 20;3(3):176-184. doi: 10.1159/000504838. eCollection 2019 Sep-Dec. Digit Biomark. 2019. PMID: 32095776 Free PMC article.
-
Point-of-critical-care diagnostics for sepsis enabled by multiplexed micro and nanosensing technologies.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep;13(5):e1701. doi: 10.1002/wnan.1701. Epub 2021 Mar 1. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 33650293 Free PMC article. Review.
-
Identification of Patient Perceptions That Can Affect the Uptake of Interventions Using Biometric Monitoring Devices: Systematic Review of Randomized Controlled Trials.J Med Internet Res. 2020 Sep 11;22(9):e18986. doi: 10.2196/18986. J Med Internet Res. 2020. PMID: 32915153 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources